We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
(+9.5%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
7.83%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$8.42M |
| 2 |
Marathon Petroleum
MPC
|
+$5.47M |
| 3 |
Liberty Global Class C
LBTYK
|
+$5.39M |
| 4 |
O'Reilly Automotive
ORLY
|
+$5.32M |
| 5 |
Crocs
CROX
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.6M |
| 2 |
Tapestry
TPR
|
+$12M |
| 3 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$8.32M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$6.96M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$6.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.95% |
| 2 | Consumer Discretionary | 2.51% |
| 3 | Technology | 1.96% |
| 4 | Energy | 1.43% |
| 5 | Communication Services | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Titan Machinery
TITN
$396M
| $721K | 0.04% |
+35,000
| New | +$588K |
|
|
ARQL
427
CALL
DELISTED
Arqule Inc
ARQL
| $708K | 0.04% |
64,400
-600
| -0.9% | -$4.18K |
|
|
NVTA
428
CALL
DELISTED
Invitae Corporation
NVTA
| $705K | 0.04% |
+30,000
| New | +$639K |
|
429
CALL
Assembly Biosciences
ASMB
$498M
| $703K | 0.04% |
4,342
+1,842
| +74% | +$350K |
|
430
Northern Oil and Gas
NOG
$2.3B
| $695K | 0.04% |
36,000
+24,500
| +213% | +$566K |
|
431
Teladoc Health
TDOC
$1.22B
| $691K | 0.03% |
+10,400
| New | +$606K |
|
432
CALL
Freshpet
FRPT
$2.93B
| $683K | 0.03% |
15,000
| – | – |
|
|
KYNB
433
CALL
Kyntra Bio
KYNB
$27.2M
| $678K | 0.03% |
+600
| New | +$657K |
|
|
KYNB
434
PUT
Kyntra Bio
KYNB
$27.2M
| $678K | 0.03% |
600
-2,204
| -79% | -$2.41M |
|
|
GPOR
435
DELISTED
Gulfport Energy Corp.
GPOR
| $678K | 0.03% |
138,000
-72,000
| -34% | -$459K |
|
436
Texas Roadhouse
TXRH
$13.5B
| $671K | 0.03% |
12,500
+2,500
| +25% | +$141K |
|
|
I
437
DELISTED
INTELSAT S. A.
I
| $671K | 0.03% |
+34,500
| New | +$669K |
|
438
CALL
Bunge Global
BG
$20.4B
| $669K | 0.03% |
12,000
| – | – |
|
439
PUT
Forte Biosciences
FBRX
$1.57B
| $668K | 0.03% |
+267
| New | +$792K |
|
440
Dell
DELL
$262B
| $661K | 0.03% |
+25,649
| New | +$800K |
|
441
Robert Half
RHI
$3.87B
| $655K | 0.03% |
+11,500
| New | +$686K |
|
442
CALL
Mercer International
MERC
$42.3M
| $651K | 0.03% |
+42,100
| New | +$633K |
|
443
Pan American Silver
PAAS
$18.2B
| $645K | 0.03% |
50,000
| – | – |
|
444
Alarm.com
ALRM
$2.71B
| $643K | 0.03% |
+12,000
| New | +$740K |
|
445
Kornit Digital
KRNT
$705M
| $632K | 0.03% |
20,000
-3,000
| -13% | -$82.8K |
|
446
PUT
Strategy Inc
MSTR
$34.1B
| $631K | 0.03% |
44,000
-451,000
| -91% | -$6.37M |
|
|
AVYA
447
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $624K | 0.03% |
+52,400
| New | +$801K |
|
448
PUT
B&G Foods
BGS
$287M
| $620K | 0.03% |
+29,800
| New | +$687K |
|
|
FLXN
449
CALL
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $615K | 0.03% |
+50,000
| New | +$577K |
|
450
National Vision
EYE
$1.77B
| $614K | 0.03% |
+20,000
| New | +$573K |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2019 Portfolio in Review
As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.
- Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
- Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
- Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
- Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
- Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
- Caption Management opened 395 new positions and closed 294 in Q2 2019.
- Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.
Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.